z-logo
Premium
IgG subclass profile among anti‐Glutathione S‐transferase T1 antibodies in post‐transplant de novo immune hepatitis
Author(s) -
Aguilera Isabel,
MartinezBravo Maria José,
Sousa Jose Manuel,
PozoBorrego Antonio Jesús,
NúñezRoldán Antonio
Publication year - 2016
Publication title -
clinical transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 76
eISSN - 1399-0012
pISSN - 0902-0063
DOI - 10.1111/ctr.12675
Subject(s) - medicine , antibody , subclass , liver transplantation , immunology , immune system , liver disease , pathogenesis , hepatitis , transplantation , antigen
Although the pathogenic pathways leading to de novo immune hepatitis ( IH ) are not completely understood, we have shown strong evidences of an antidonor response against Glutathione S‐transferase T1 ( GSTT 1), an antigen exclusively expressed in the donor liver. The first sign of this process is the production of GSTT 1 antibodies that, in 25% of the cases, will precede de novo IH . Because the presence of the antibodies is not sufficient to trigger the disease, we aimed to study GSTT 1 IgG subclasses in a group of 18 liver transplant patients, 12 that developed de novo IH and 6 that remained free of disease. Surprisingly, the predominant subclasses were IgG1‐ GSTT 1 and IgG4‐ GSTT 1 . The presence of IgG4‐expressing plasma cells was also investigated in 10 available liver biopsies. Six biopsies coinciding with diagnosis showed a mean value of 32.8 IgG4+ plasma cells/hpf vs. 5.55 in patients without the disease. We have not found a distinctive GSTT 1‐IgG profile in patients with de novo IH , but the ratio IgG1‐ GSTT 1 /IgG4‐ GSTT 1 in samples from close to the time of diagnosis seemed to be important. The novel finding of abundant IgG4‐ GSTT 1 in liver transplantation is intriguing, but their possible role in pathogenesis of de novo IH remains unknown.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here